` Comparison: IMUC vs CYTH - Alpha Spread

IMUC
vs
CYTH

Over the past 12 months, IMUC has outperformed CYTH, delivering a return of +6% compared to the CYTH's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
IMUC
CYTH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

IMUC Intrinsic Value
HIDDEN
Show
CYTH Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
ImmunoCellular Therapeutics Ltd
OTC:IMUC
0.14 USD
Cyclo Therapeutics Inc
NASDAQ:CYTH
99 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
IMUC, CYTH

IMUC
CYTH
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
ImmunoCellular Therapeutics Ltd
Revenue
Cyclo Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
IMUC, CYTH

IMUC
CYTH
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
ImmunoCellular Therapeutics Ltd
OTC:IMUC
Cyclo Therapeutics Inc
NASDAQ:CYTH
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

IMUC
0%
CYTH
91.2%

Operating Margin

IMUC
0%
CYTH
-2 834.1%

Net Margin

IMUC
0%
CYTH
-2 848.2%

FCF Margin

IMUC
0%
CYTH
-2 586.1%

ROE

IMUC
-1 156.3%
CYTH
341.5%

ROA

IMUC
-240.6%
CYTH
-457.1%

ROIC

IMUC
-3 556.7%
CYTH
1 154.9%

ROCE

IMUC
-312.3%
CYTH
340.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
IMUC, CYTH

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IMUC, CYTH

Performance Gap Between IMUC and CYTH
HIDDEN
Show

Performance By Year
IMUC, CYTH

Loading
IMUC
CYTH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare IMUC to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account